Scroll for more

blog

Author Jackie Hunter

Jackie Hunter

Jackie Hunter is CEO of BenevolentBio. Having worked for global pharmaceutical organisations including GSK, Proimagen and OI Pharma, Jackie has a wealth of knowledge and experience to draw on when it comes to talking about the challenges currently facing the pharmaceutical industry; the application of AI in drug development or the global conferences she has attended and contributed to.

Dec 21, 2016 jackie hunter

I'm buying science presents for Christmas this year

It’s the last week before Christmas and a good time for reflection, to pause for breath and to think about what the next year will bring.

Dec 5, 2016 jackie hunter

In five years' time… Key trends in AI healthcare

10 years ago I attended a symposium looking at the future of pharmacology and healthcare.

Oct 7, 2016 jackie hunter

What happens when you put expert human brains in a room to discuss machine brains?

These are truly exciting times for artificial intelligence (“AI”) and bioscience. This month, together with The Crick and Turing Institutes and the Wellcome Trust, we co-hosted the first of what we anticipate will be an annual symposium on ‘Artificial Intelligence in Bioscience’.